𝔖 Bobbio Scriptorium
✦   LIBER   ✦

4-Hydroxytamoxifen binds to estrogen receptors and inhibits the growth of human endometrial cancer cells in vitro

✍ Scribed by Naoki Terakawa; Ikuya Shimizu; Hiromasa Ikegami; Osamu Tanizawa; Keishi Matsumoto


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
457 KB
Volume
61
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Amphiregulin antisense oligonucleotide i
✍ Hitoshi Funatomi; Jun Itakura; Toshiyuki Ishiwata; Ira Pastan; Stewart A. Thomps πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 152 KB πŸ‘ 2 views

Human pancreatic cancers overexpress the epidermal growth factor (EGF) receptor (EGFR) and all 5 ligands that bind to this receptor, including amphiregulin. It is not known, however, whether amphiregulin contributes in an autocrine manner to enhance pancreatic cancer cell growth. Therefore, we used

Comparative binding affinities of tamoxi
✍ Carol Fabian; Lowell Tilzer; Larry Sternson πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 470 KB πŸ‘ 1 views

## Abstract The relative ability of the antiestrogen, tamoxifen, and its monohydroxy and desmethyl metabolites to displace tritiated estradiol from estrogen receptors isolated from human breast carcinoma was determined. 4‐Hydroxytamoxifen binds to the estrogen receptor with affinity equal to estrad

Recombinant antibody toxins specific for
✍ Marc Azemar; Mathias Schmidt; Friederike Arlt; Pierre Kennel; Burkhard Brandt; A πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 130 KB πŸ‘ 2 views

## Overexpression of the ErbB2 and epidermal growth factor receptor (EGFR) tyrosine kinases is frequently observed in squamous cell carcinomas of the head and neck, and has been correlated with shorter overall survival. By immunoblot analysis, we have found EGFR and ErbB2 expression in 6 out of 6 e